Dr. Renee Allen, M.D

NPI: 1578749883
Total Payments
$132,260
2024 Payments
$15.87
Companies
7
Transactions
82

Payment Breakdown by Category

Consulting$125,987 (95.3%)
Other$2,975 (2.2%)
Travel$2,546 (1.9%)
Food & Beverage$751.74 (0.6%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $125,987 59 95.3%
Travel and Lodging $2,546 9 1.9%
Honoraria $2,500 1 1.9%
Food and Beverage $751.74 12 0.6%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $475.00 1 0.4%

Top Paying Companies

Company Total Records Latest Year
Shire North American Group Inc $70,041 39 $0 (2019)
Takeda Pharmaceuticals U.S.A., Inc. $42,500 20 $0 (2021)
Clinical Innovations, LLC $9,569 3 $0 (2017)
Ferring Pharmaceuticals Inc. $6,864 13 $0 (2017)
Gen-Probe, Inc. $2,717 2 $0 (2022)
Gen-Probe Sales & Service, Inc. $552.21 4 $0 (2022)
Boston Scientific Corporation $15.87 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $15.87 1 Boston Scientific Corporation ($15.87)
2022 $3,270 6 Gen-Probe, Inc. ($2,717)
2021 $16,500 8 Takeda Pharmaceuticals U.S.A., Inc. ($16,500)
2020 $26,000 12 Takeda Pharmaceuticals U.S.A., Inc. ($26,000)
2019 $27,700 15 Shire North American Group Inc ($27,700)
2018 $26,693 14 Shire North American Group Inc ($26,693)
2017 $32,081 26 Shire North American Group Inc ($15,648)

All Payment Transactions

82 individual payment records from CMS Open Payments — Page 1 of 4

Date Company Product Nature Form Amount Type
06/12/2024 Boston Scientific Corporation Food and Beverage In-kind items and services $15.87 General
Category: Clinical Trial Product_NMD
07/25/2022 Gen-Probe, Inc. APTIMA (Device) Travel and Lodging Cash or cash equivalent $217.31 General
Category: Diagnostics
06/14/2022 Gen-Probe Sales & Service, Inc. Travel and Lodging In-kind items and services $293.22 General
06/14/2022 Gen-Probe Sales & Service, Inc. APTIMA (Device) Food and Beverage In-kind items and services $50.32 General
Category: Diagnostics
06/09/2022 Gen-Probe Sales & Service, Inc. APTIMA (Device) Food and Beverage In-kind items and services $54.74 General
Category: Diagnostics
06/03/2022 Gen-Probe Sales & Service, Inc. APTIMA (Device) Food and Beverage In-kind items and services $153.93 General
Category: Diagnostics
05/30/2022 Gen-Probe, Inc. APTIMA (Device) Honoraria Cash or cash equivalent $2,500.00 General
Category: Diagnostics
08/10/2021 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $1,133.33 General
07/15/2021 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,266.67 General
06/10/2021 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,266.67 General
05/11/2021 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,166.67 General
04/12/2021 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,166.67 General
03/08/2021 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,166.67 General
02/09/2021 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,166.67 General
01/12/2021 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,166.67 General
12/09/2020 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,166.67 General
11/10/2020 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,166.67 General
10/09/2020 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,166.67 General
09/09/2020 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,166.67 General
08/11/2020 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,166.67 General
06/24/2020 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,166.67 General
06/08/2020 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,166.67 General
05/06/2020 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,166.67 General
04/07/2020 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,166.67 General
03/04/2020 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,166.67 General

About Dr. Renee Allen, M.D

Dr. Renee Allen, M.D is a Obstetrics & Gynecology healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/16/2008. The National Provider Identifier (NPI) number assigned to this provider is 1578749883.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Renee Allen, M.D has received a total of $132,260 in payments from pharmaceutical and medical device companies, with $15.87 received in 2024. These payments were reported across 82 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($125,987).

Practice Information

  • Specialty Obstetrics & Gynecology
  • Location Atlanta, GA
  • Active Since 01/16/2008
  • Last Updated 02/24/2025
  • Taxonomy Code 207V00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1578749883

Products in Payments

  • BABYLANCE SAFETY HEEL STICKS (Device) $9,569
  • CERVIDIL (Drug) $6,864
  • APTIMA (Device) $2,976

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Obstetrics & Gynecology Doctors in Atlanta